Literature DB >> 10882791

Nerve growth factor and neurotrophin-3 modulate the rabies infection of adult sensory neurons in primary cultures.

J E Castellanos1, M Martínez, O Acosta, H Hurtado.   

Abstract

With the aim of determining if the proportion of rabies virus (RV)-infected adult neurons from dorsal root ganglion are affected by in vitro treatment with different neurotrophins, experiments using Nerve Growth Factor (NGF), Brain Derived Neurotrophic Factor (BDNF) or Neurotrophin-3 (NT-3) as supplements for cells in culture were performed. Cultures treated with three different concentrations of each of the neurotrophins mentioned were infected with Challenge Virus Standard RV strain. An indirect immunoperoxidase technique was performed for the detection and counting of infected cells. NGF (2 ngml(-1) and 10 ngml(-1)) and NT-3 (1 ngml(-1) and 5 ngml(-1)) induced a significant reduction of infected neurons. None of the cultures treated with BDNF showed changes in the percentage of infected neurons. Likewise, the proportion of infected non-neuronal cells (Schwann cells and fibroblasts) was not altered by the treatment with neurotrophins. In addition, morphometric analysis of total and virus-immunoreactive neurons in culture were carried out, the neurotrophin treatment induced variations in the profile of neurons preferentially infected, since cell diameters in the infected cell population are different in the presence of NGF and NT-3. Data presented here could indicate a putative participation of neurotrophin receptor or biochemical modifications induced by neurotrophin treatment that affect the infection. The primary culture of dorsal root ganglion cells from adult mice is a very useful model for studying the basic phenomena of the RV-neuron interaction.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10882791     DOI: 10.1016/s0006-8993(00)02408-2

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  9 in total

1.  Role of oxidative stress in rabies virus infection of adult mouse dorsal root ganglion neurons.

Authors:  Alan C Jackson; Wafa Kammouni; Elena Zherebitskaya; Paul Fernyhough
Journal:  J Virol       Date:  2010-02-24       Impact factor: 5.103

2.  Effect of rabies virus infection on gene expression in mouse brain.

Authors:  M Prosniak; D C Hooper; B Dietzschold; H Koprowski
Journal:  Proc Natl Acad Sci U S A       Date:  2001-02-27       Impact factor: 11.205

3.  Studying neurotrophin antiviral effect on rabies-infected dorsal root ganglia cultures.

Authors:  Jaime E Castellanos; Marlén Martïnez-Gutierrez; Hernán Hurtado; Raid Kassis; Hervé Bourhy; Orlando Acosta; Monique Lafon
Journal:  J Neurovirol       Date:  2005-08       Impact factor: 2.643

4.  Differential use of the nicotinic receptor by rabies virus based upon substrate origin.

Authors:  David R Castañeda-Castellanos; Jaime E Castellanos; Hernán Hurtado
Journal:  J Neurovirol       Date:  2002-04       Impact factor: 2.643

5.  Rabies virus is not cytolytic for rat spinal motoneurons in vitro.

Authors:  Céline Guigoni; Patrice Coulon
Journal:  J Neurovirol       Date:  2002-08       Impact factor: 2.643

6.  The rabies virus glycoprotein receptor p75NTR is not essential for rabies virus infection.

Authors:  Christine Tuffereau; Klaus Schmidt; Christelle Langevin; Florence Lafay; Georg Dechant; Martin Koltzenburg
Journal:  J Virol       Date:  2007-10-10       Impact factor: 5.103

7.  A novel lymphocyte signaling defect: trk A mutation in the syndrome of congenital insensitivity to pain and anhidrosis (CIPA).

Authors:  I Melamed; J Levy; R Parvari; E W Gelfand
Journal:  J Clin Immunol       Date:  2004-07       Impact factor: 8.317

Review 8.  Role of trophic factors on neuroimmunity in neurodegenerative infectious diseases.

Authors:  Dianne Langford; Eliezer Masliah
Journal:  J Neurovirol       Date:  2002-12       Impact factor: 3.739

9.  Rabies Virus Hijacks and accelerates the p75NTR retrograde axonal transport machinery.

Authors:  Shani Gluska; Eitan Erez Zahavi; Michael Chein; Tal Gradus; Anja Bauer; Stefan Finke; Eran Perlson
Journal:  PLoS Pathog       Date:  2014-08-28       Impact factor: 6.823

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.